ARCT
Price
$13.44
Change
+$0.13 (+0.98%)
Updated
Jul 15, 03:48 PM (EDT)
Capitalization
360.98M
27 days until earnings call
BNTX
Price
$111.00
Change
-$1.89 (-1.67%)
Updated
Jul 14 closing price
Capitalization
26.68B
20 days until earnings call
Interact to see
Advertisement

ARCT vs BNTX

Header iconARCT vs BNTX Comparison
Open Charts ARCT vs BNTXBanner chart's image
Arcturus Therapeutics Holdings
Price$13.44
Change+$0.13 (+0.98%)
Volume$443
Capitalization360.98M
BioNTech SE American Depositary Share
Price$111.00
Change-$1.89 (-1.67%)
Volume$441.61K
Capitalization26.68B
ARCT vs BNTX Comparison Chart in %
Loading...
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARCT vs. BNTX commentary
Jul 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARCT is a Hold and BNTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 15, 2025
Stock price -- (ARCT: $13.31 vs. BNTX: $111.00)
Brand notoriety: ARCT and BNTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARCT: 55% vs. BNTX: 48%
Market capitalization -- ARCT: $360.98M vs. BNTX: $26.68B
ARCT [@Biotechnology] is valued at $360.98M. BNTX’s [@Biotechnology] market capitalization is $26.68B. The market cap for tickers in the [@Biotechnology] industry ranges from $305.86B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARCT’s FA Score shows that 0 FA rating(s) are green whileBNTX’s FA Score has 2 green FA rating(s).

  • ARCT’s FA Score: 0 green, 5 red.
  • BNTX’s FA Score: 2 green, 3 red.
According to our system of comparison, BNTX is a better buy in the long-term than ARCT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARCT’s TA Score shows that 2 TA indicator(s) are bullish while BNTX’s TA Score has 3 bullish TA indicator(s).

  • ARCT’s TA Score: 2 bullish, 6 bearish.
  • BNTX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BNTX is a better buy in the short-term than ARCT.

Price Growth

ARCT (@Biotechnology) experienced а -0.37% price change this week, while BNTX (@Biotechnology) price change was +0.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.66%. For the same industry, the average monthly price growth was +18.53%, and the average quarterly price growth was +31.91%.

Reported Earning Dates

ARCT is expected to report earnings on Aug 11, 2025.

BNTX is expected to report earnings on Nov 03, 2025.

Industries' Descriptions

@Biotechnology (+2.66% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BNTX($26.7B) has a higher market cap than ARCT($361M). BNTX YTD gains are higher at: -2.589 vs. ARCT (-21.567). ARCT has higher annual earnings (EBITDA): -63.92M vs. BNTX (-447M). BNTX has more cash in the bank: 14.1B vs. ARCT (217M). ARCT has less debt than BNTX: ARCT (42.7M) vs BNTX (293M). BNTX has higher revenues than ARCT: BNTX (2.75B) vs ARCT (131M).
ARCTBNTXARCT / BNTX
Capitalization361M26.7B1%
EBITDA-63.92M-447M14%
Gain YTD-21.567-2.589833%
P/E RatioN/A161.76-
Revenue131M2.75B5%
Total Cash217M14.1B2%
Total Debt42.7M293M15%
FUNDAMENTALS RATINGS
ARCT: Fundamental Ratings
ARCT
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARCTBNTX
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
77%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
75%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ARCT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BNTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FCODF1753.63N/A
N/A
COMPAGNIE DE L ODET
HCTPF0.13N/A
N/A
Hutchison Port Holdings Trust
LSFG46.15N/A
N/A
Lifestore Financial Group, Inc.
SFTBY34.81-0.91
-2.55%
Softbank Group Corp
TRLEF0.02N/A
-3.49%
Trillion Energy International Inc.

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been loosely correlated with SMMT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if BNTX jumps, then SMMT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
-1.67%
SMMT - BNTX
51%
Loosely correlated
+1.60%
TIL - BNTX
50%
Loosely correlated
N/A
MRNA - BNTX
48%
Loosely correlated
-2.29%
ARCT - BNTX
47%
Loosely correlated
-3.41%
KYMR - BNTX
43%
Loosely correlated
+0.94%
More